Notably, according to Horiguchi et al. (Horiguchi et al., 2008), if STAT3 activation is localized within hepatocytes, suppression of STAT3 activation should have resulted in greater hepatic steatosis, and higher serum and hepatic TG levels. Here, STAT3 is linked to fatty liver disease.